亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

湖北廠家專業(yè)生產(chǎn)氟康唑中間體&*CAS:86404-63-

 
 
單價 950.00 / 公斤對比
銷量 暫無
發(fā)貨 湖北隨州市付款后24小時內(nèi)
庫存 1000公斤起訂1公斤
品牌 佳科
型號 86404-63-9
規(guī)格 25kg/桶
過期 長期有效
更新 2020-12-22 09:16
 

隨州佳科醫(yī)藥化工有限公司銷售二部

企業(yè)會員第14年
資料未認證
保證金未繳納
  • 湖北-隨州市
  • 上次登錄 2020-12-22
  • 高飛 (女士)   銷售經(jīng)理
詳細說明

  氟康唑中間體
CAS號:86404-63-9
別名:2.4-二氟2-(1H-1.2.4-三氮唑)-苯乙酮
英文名稱:2-(1H-1.2.4-triazol)-2.4-difluoroacetophenone
熔點:103℃-108℃
干燥失重:≤1.0%
標準;企業(yè)標準
含量;≥98%
性狀;淡黃色結(jié)晶粉末
用途:氟康唑中間體
包裝;25kg/桶
舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
湖北廠家專業(yè)生產(chǎn)三氟甲磺酸*CAS:1493-13-6*含量 湖北廠家專業(yè)生產(chǎn)芬布芬*CAS:36330-85-5* 含量 湖北廠家專業(yè)生產(chǎn)甘草次酸*CAS:1449-05-4*99% 湖北廠家專業(yè)生產(chǎn)阿戈美拉汀*CAS: 138112-76- 湖北廠家專業(yè)生產(chǎn)莫匹羅星*CAS:12650-69-0*含量 卡倍他濱中間體/CAS162204-20-8/廠家生產(chǎn) 培美曲塞二鈉@CAS150399-23-8@谷氨酸二鈉供應(yīng)商 半合成脂肪酸甘油酯/混合脂肪酸甘油酯
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |